Developer docs
API playgroundTry for free, no card

Search company profiles

Earlybird Venture Capital

Full company profile

uuid00006f9

Namestring
Earlybird Venture Capital
Legal namestring
Earlybird GmbH & Co. KG
Websiteurl
earlybird.com
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Earlybird Venture Capital is a Berlin-headquartered, European venture capital partnership founded in 1997 that invests from Pre-Seed to Series A in emerging technology companies, with a stated 20%/60%/20% allocation across those stages and initial tickets up to €12 million. The firm operates a multi-strategy platform spanning the flagship tech fund (Fund VIII closed at €360 million in April 2026, the largest in firm history), Earlybird Health for life sciences and biotech, Earlybird Vision Lab as a pro-bono pre-seed incubator for migrant-background founders, and the recently launched E2D €500 million Franco-German dual-use and defence growth fund with AVP. Total assets under management stand at €2.5 billion across these vehicles.

The firm's central technology layer is EagleEye, a proprietary AI and data platform that integrates machine learning, browser fingerprinting, tracking pixels, and data engineering across sourcing, screening, due diligence, portfolio value creation, and exit identification. EagleEye has assessed more than 20 million founders and 10 million companies, covers 95% of relevant opportunities, holds a 50% share of active deal flow, and reportedly delivers a 200% team-efficiency multiplier. The platform underpins Earlybird's positioning as 'The Augmented VC'.

Earlybird makes money through traditional fund management fees and carried interest across its fund vehicles, supplemented by small convertible-loan investments (€25K) into Vision Lab cohort companies. The firm employs between 101 and 250 staff across offices in Berlin (headquarters), London, Munich, Milan, and Dublin, with sector-specialised General Partners covering DeepTech, FinTech/InsurTech, AI and infrastructure, Enterprise Software, and Web3. Its 29-year track record includes 9 IPOs and 41 trade sales, with portfolio highlights spanning UiPath, N26, Aleph Alpha, Marvel Fusion, Isar Aerospace, Black Forest Labs, and Aiven.

Short descriptiontext

Earlybird is a Berlin-based European venture capital firm founded in 1997 that invests Pre-Seed to Series A (initial tickets up to €12M) in emerging tech founders across fintech, AI, DeepTech, and life sciences, managing €2.5B in AUM via its EagleEye AI-powered sourcing platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, early-stage tech funding, seed round investment, startup equity financing, pan-European tech funds
Product category
Early-Stage Venture Capital
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Fund management fees and carried interest
TypeManaged Services
Description

Earns management fees and performance carry across multiple fund strategies including Fund VIII (€360M closed April 2026), Earlybird Health, Earlybird Growth Opps V, Earlybird DEF I/II, Earlybird DWES, and the E2D growth fund (€500M with AVP). Total AUM of €2.5B across fund streams.

tech.eu
2Vision Lab convertible loan investments
TypeLicensing Royalties
Description

Provides EUR 25K convertible loan investments to pre-seed founders with migration backgrounds as part of the six-month Vision Lab program.

earlybird.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Earlybird Health
Description

Separate investment strategy focused on life science breakthroughs accelerated by data-driven analytics and operations

earlybird.com
+3 more records
Core offering1 text field

Earlybird Venture Capital is a European venture capital firm that invests Pre-Seed to Series A capital in technology startups, with initial ticket sizes up to €12 million. The firm manages €2.5 billion in assets under management across multiple fund strategies (including the €360M Fund VIII, Earlybird Health, Growth Opportunities V, E2D dual-use/defence, and Vision Lab impact fund), backs approximately 20 new companies per year, and supports founders with board-level guidance, network access, talent sourcing, and follow-on capital.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 200% team efficiency boost via EagleEye AI/data platform
+5 more records
Product overview1 text field

Earlybird Venture Capital operates as an integrated platform that combines traditional early-stage venture investing with proprietary technology and dedicated programmes. The core intelligence layer is EagleEye, Earlybird's proprietary AI and data platform that powers sourcing, screening, due diligence, and portfolio value creation across all funds. Around this layer sit multiple investment vehicles, including the tech-focused Earlybird Fund VIII (€360M, closed April 2026), the separate Earlybird Health strategy for life sciences, and Vision Lab, Germany's first VC incubator and impact fund supporting pre-seed startups by entrepreneurs with migration backgrounds. Together, EagleEye plus the Fund VIII and Earlybird Health investment vehicles plus Vision Lab form Earlybird's 'Augmented VC' offering, applying AI-driven insights to the full Pre-Seed to Series A lifecycle.

Product and service5 records
1Earlybird Fund VIII
CategoryVenture Capital Fund
Description

Earlybird's flagship eighth early-stage technology venture fund providing equity capital to European Pre-Seed, Seed, and Series A founders, with initial ticket sizes up to €12M and consistent three-to-four-year fund cadence ensuring follow-on capital.

2Earlybird Health
CategoryHealthcare Venture Capital Fund
Description

Dedicated investment strategy focused on life sciences and biotech, investing in data-enabled therapeutics, medtech, and AI-driven healthcare companies across Europe.

3Vision Lab Pre-Seed Incubator and Impact Fund
CategoryImpact Incubator and Pre-Seed Fund
Description

Pro-bono pre-seed incubator and impact fund providing €25K convertible loan investments, mentorship, and a six-month workshop curriculum to first-generation migrant founders building startups in Germany with distinctive MVPs and clear USPs.

4E2D European Dual-Use and Defence Growth Fund
CategoryDual-Use and Defence Growth Fund
Description

€500M Franco-German growth-stage fund investing in European dual-use and defence technology companies across space, air, land, maritime, and subsurface domains, with an average ticket size of approximately €25M per company.

5EagleEye Proprietary AI and Data Platform
CategoryProprietary AI and Data Platform
Description

Earlybird's proprietary AI and data platform branded as 'The Augmented VC' that augments venture capital decision-making across sourcing, screening, due diligence, portfolio value creation, and exit identification. Has assessed over 20 million founders and over 10 million companies to date, delivering a reported 200% team efficiency boost, 95% sourcing coverage of relevant opportunities, and 50% share of active deal flow.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Nordic-headquartered European venture capital firm investing from seed to Series A across Northern Europe. Highly comparable in stage discipline and fund size; a peer for Nordic and DACH early-stage deals, with comparable brand strength among European founders.

TypeDirect peer
Description

London-headquartered European venture capital firm founded by a Skype co-founder, investing across early to growth stages in European tech. Comparable in pan-European reach, brand strength among founders, and stage breadth; a frequent co-investor and competitor for European AI and deep-tech deals.

TypeDirect peer
Description

European venture capital arm of EQT, investing across Seed to Series B in European tech. Comparable in pan-European mandate and stage coverage, with deeper capital backing through the EQT platform; a frequent competitor and co-investor for European growth-stage deals.

TypeDirect peer
Description

Vienna-based European venture capital firm investing in pre-seed to Series A tech across fintech, deep tech, and industrial tech. Directly comparable stage focus and geographic scope; a frequent co-investor with Earlybird (e.g., SpAItial seed round).

TypeDirect peer
Description

London-based European venture capital firm focused on early-stage technology investments from Seed to Series A. Highly comparable in stage focus, geographic emphasis on European founders, and fund size bracket; a consistent peer for early-stage European rounds.

TypeEmerging player
Description

London-based European venture capital firm focused on B2B SaaS and enterprise tech from seed to Series A. Partial overlap with Earlybird's enterprise software practice (Paul Klemm's vertical); a more sector-focused peer rather than a direct stage match.

TypeDirect peer
Description

Pan-European venture capital firm with comparable Pre-Seed to Series A coverage across applications, fintech, and frontier tech. Both firms are among the most established European VCs, share a similar multi-fund structure, and frequently co-invest or compete on the same European tech deals.

TypeDirect peer
Description

Nordic-anchored European venture capital firm investing from seed to growth in European tech. Comparable in stage breadth and founder brand pull across the Nordics and broader Europe; a peer for trans-Nordic and pan-European early-stage rounds.

TypeBroad incumbent
Description

Global venture capital firm with a strong London/European presence investing across seed to growth stages. Larger and more globally diversified than Earlybird but a direct competitor for European Series A and follow-on rounds in SaaS, fintech, and consumer.

TypeDirect peer
Description

Munich- and Berlin-based German venture capital firm investing across seed to growth stages. Directly comparable geographic footprint, stage focus, and sector breadth; a frequent co-investor in DACH deals (e.g., Isar Aerospace alongside Earlybird).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers26 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment364 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Earlybird Venture Capital

Early-Stage Venture Capitalearlybird.com

Earlybird is a Berlin-based European venture capital firm founded in 1997 that invests Pre-Seed to Series A (initial tickets up to €12M) in emerging tech founders across fintech, AI, DeepTech, and life sciences, managing €2.5B in AUM via its EagleEye AI-powered sourcing platform.

What Earlybird Venture Capital does

Earlybird Venture Capital is a Berlin-headquartered, European venture capital partnership founded in 1997 that invests from Pre-Seed to Series A in emerging technology companies, with a stated 20%/60%/20% allocation across those stages and initial tickets up to €12 million. The firm operates a multi-strategy platform spanning the flagship tech fund (Fund VIII closed at €360 million in April 2026, the largest in firm history), Earlybird Health for life sciences and biotech, Earlybird Vision Lab as a pro-bono pre-seed incubator for migrant-background founders, and the recently launched E2D €500 million Franco-German dual-use and defence growth fund with AVP. Total assets under management stand at €2.5 billion across these vehicles.

The firm's central technology layer is EagleEye, a proprietary AI and data platform that integrates machine learning, browser fingerprinting, tracking pixels, and data engineering across sourcing, screening, due diligence, portfolio value creation, and exit identification. EagleEye has assessed more than 20 million founders and 10 million companies, covers 95% of relevant opportunities, holds a 50% share of active deal flow, and reportedly delivers a 200% team-efficiency multiplier. The platform underpins Earlybird's positioning as 'The Augmented VC'.

Earlybird makes money through traditional fund management fees and carried interest across its fund vehicles, supplemented by small convertible-loan investments (€25K) into Vision Lab cohort companies. The firm employs between 101 and 250 staff across offices in Berlin (headquarters), London, Munich, Milan, and Dublin, with sector-specialised General Partners covering DeepTech, FinTech/InsurTech, AI and infrastructure, Enterprise Software, and Web3. Its 29-year track record includes 9 IPOs and 41 trade sales, with portfolio highlights spanning UiPath, N26, Aleph Alpha, Marvel Fusion, Isar Aerospace, Black Forest Labs, and Aiven.

Earlybird Venture Capital firmographics

Firmographics
Name
Earlybird Venture Capital
Legal name
Earlybird GmbH & Co. KG
Website
https://earlybird.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
Earlybird is a Berlin-based European venture capital firm founded in 1997 that invests Pre-Seed to Series A (initial tickets up to €12M) in emerging tech founders across fintech, AI, DeepTech, and life sciences, managing €2.5B in AUM via its EagleEye AI-powered sourcing platform.
Ownership category
akta.pro rank

Where Earlybird Venture Capital is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices5 records

Markets served

Earlybird Venture Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Fund management fees and carried interest: Earns management fees and performance carry across multiple fund strategies including Fund VIII (€360M closed April 2026), Earlybird Health, Earlybird Growth Opps V, Earlybird DEF I/II, Earlybird DWES, and the E2D growth fund (€500M with AVP). Total AUM of €2.5B across fund streams.
  2. Vision Lab convertible loan investments: Provides EUR 25K convertible loan investments to pre-seed founders with migration backgrounds as part of the six-month Vision Lab program.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Earlybird Venture Capital product offering

Product offering

Core offering

Earlybird Venture Capital is a European venture capital firm that invests Pre-Seed to Series A capital in technology startups, with initial ticket sizes up to €12 million. The firm manages €2.5 billion in assets under management across multiple fund strategies (including the €360M Fund VIII, Earlybird Health, Growth Opportunities V, E2D dual-use/defence, and Vision Lab impact fund), backs approximately 20 new companies per year, and supports founders with board-level guidance, network access, talent sourcing, and follow-on capital.

Product overview

Earlybird Venture Capital operates as an integrated platform that combines traditional early-stage venture investing with proprietary technology and dedicated programmes. The core intelligence layer is EagleEye, Earlybird's proprietary AI and data platform that powers sourcing, screening, due diligence, and portfolio value creation across all funds. Around this layer sit multiple investment vehicles, including the tech-focused Earlybird Fund VIII (€360M, closed April 2026), the separate Earlybird Health strategy for life sciences, and Vision Lab, Germany's first VC incubator and impact fund supporting pre-seed startups by entrepreneurs with migration backgrounds. Together, EagleEye plus the Fund VIII and Earlybird Health investment vehicles plus Vision Lab form Earlybird's 'Augmented VC' offering, applying AI-driven insights to the full Pre-Seed to Series A lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

  • Earlybird Health: Separate investment strategy focused on life science breakthroughs accelerated by data-driven analytics and operations
  • Earlybird Vision Lab
  • EagleEye
  • E2D

Products and services

  • Earlybird Fund VIII Earlybird's flagship eighth early-stage technology venture fund providing equity capital to European Pre-Seed, Seed, and Series A founders, with initial ticket sizes up to €12M and consistent three-to-four-year fund cadence ensuring follow-on capital.
  • Earlybird Health Dedicated investment strategy focused on life sciences and biotech, investing in data-enabled therapeutics, medtech, and AI-driven healthcare companies across Europe.
  • Vision Lab Pre-Seed Incubator and Impact Fund Pro-bono pre-seed incubator and impact fund providing €25K convertible loan investments, mentorship, and a six-month workshop curriculum to first-generation migrant founders building startups in Germany with distinctive MVPs and clear USPs.
  • E2D European Dual-Use and Defence Growth Fund €500M Franco-German growth-stage fund investing in European dual-use and defence technology companies across space, air, land, maritime, and subsurface domains, with an average ticket size of approximately €25M per company.
  • EagleEye Proprietary AI and Data Platform Earlybird's proprietary AI and data platform branded as 'The Augmented VC' that augments venture capital decision-making across sourcing, screening, due diligence, portfolio value creation, and exit identification. Has assessed over 20 million founders and over 10 million companies to date, delivering a reported 200% team efficiency boost, 95% sourcing coverage of relevant opportunities, and 50% share of active deal flow.

Quantifiable outcome

  • 200% team efficiency boost via EagleEye AI/data platform
  • +5 more outcomes

Companies that use Earlybird Venture Capital

Customer profile

Named customers26 records

Segments6 records

Ideal customer profiles6 records

Earlybird Venture Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Earlybird Venture Capital partnerships and signals

Strategic signal

Recent moves8 records

Expansion highlights6 records

Earlybird Venture Capital competitors and assessment

Company assessment

Direct peers

  • Creandum: Nordic-headquartered European venture capital firm investing from seed to Series A across Northern Europe. Highly comparable in stage discipline and fund size; a peer for Nordic and DACH early-stage deals, with comparable brand strength among European founders.
  • Atomico: London-headquartered European venture capital firm founded by a Skype co-founder, investing across early to growth stages in European tech. Comparable in pan-European reach, brand strength among founders, and stage breadth; a frequent co-investor and competitor for European AI and deep-tech deals.
  • EQT Ventures: European venture capital arm of EQT, investing across Seed to Series B in European tech. Comparable in pan-European mandate and stage coverage, with deeper capital backing through the EQT platform; a frequent competitor and co-investor for European growth-stage deals.
  • Speedinvest: Vienna-based European venture capital firm investing in pre-seed to Series A tech across fintech, deep tech, and industrial tech. Directly comparable stage focus and geographic scope; a frequent co-investor with Earlybird (e.g., SpAItial seed round).
  • Balderton Capital: London-based European venture capital firm focused on early-stage technology investments from Seed to Series A. Highly comparable in stage focus, geographic emphasis on European founders, and fund size bracket; a consistent peer for early-stage European rounds.
  • Index Ventures: Pan-European venture capital firm with comparable Pre-Seed to Series A coverage across applications, fintech, and frontier tech. Both firms are among the most established European VCs, share a similar multi-fund structure, and frequently co-invest or compete on the same European tech deals.
  • Northzone: Nordic-anchored European venture capital firm investing from seed to growth in European tech. Comparable in stage breadth and founder brand pull across the Nordics and broader Europe; a peer for trans-Nordic and pan-European early-stage rounds.
  • HV Capital: Munich- and Berlin-based German venture capital firm investing across seed to growth stages. Directly comparable geographic footprint, stage focus, and sector breadth; a frequent co-investor in DACH deals (e.g., Isar Aerospace alongside Earlybird).

Emerging players

  • Notion Capital: London-based European venture capital firm focused on B2B SaaS and enterprise tech from seed to Series A. Partial overlap with Earlybird's enterprise software practice (Paul Klemm's vertical); a more sector-focused peer rather than a direct stage match.

Broad incumbents

  • Accel: Global venture capital firm with a strong London/European presence investing across seed to growth stages. Larger and more globally diversified than Earlybird but a direct competitor for European Series A and follow-on rounds in SaaS, fintech, and consumer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Earlybird Venture Capital social profiles

Digital presence

Earlybird Venture Capital compliance and trust

Trust signal

Compliance2 records

Earlybird Venture Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Earlybird Venture Capital leadership team

Management profile

Number of profiles

Profiles15 records

Earlybird Venture Capital subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Earlybird Venture Capital funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Earlybird Venture Capital M&A and investment

M&A and investment

M&A1 record

Investments364 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Earlybird Venture Capital

What does Earlybird Venture Capital do?

Earlybird Venture Capital is a European venture capital firm that invests Pre-Seed to Series A capital in technology startups, with initial ticket sizes up to €12 million. The firm manages €2.5 billion in assets under management across multiple fund strategies (including the €360M Fund VIII, Earlybird Health, Growth Opportunities V, E2D dual-use/defence, and Vision Lab impact fund), backs approximately 20 new companies per year, and supports founders with board-level guidance, network access, talent sourcing, and follow-on capital.

Is Earlybird Venture Capital a public or private company?

Earlybird Venture Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Earlybird Venture Capital founded?

Earlybird Venture Capital was founded in 1997. It employs 101 to 250 people.

Where is Earlybird Venture Capital based?

Earlybird Venture Capital is headquartered in Berlin, Germany, in the Europe region.

How does Earlybird Venture Capital make money?

Two revenue lines are on record. Fund management fees and carried interest is the primary driver. The others are vision Lab convertible loan investments.

Who are Earlybird Venture Capital's main competitors?

Direct peers on record are Creandum, Atomico, EQT Ventures, Speedinvest, Balderton Capital, Index Ventures, Northzone and HV Capital. Notion Capital is listed as an emerging player. Accel is listed as a broad incumbent.

Does Earlybird Venture Capital have an API?

No public API is recorded for Earlybird Venture Capital.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0ColibriTD Raises €4 Million Seed Round Led By Earlybird Venture CapitalColibriTD, a French quantum software firm, raised €4 million in seed funding led by Earlybird Venture Capital, with participation from SymbiaVC and Medin VC. The funds will support R&D of its H-DES solver and hiring, following a €1 million pre-seed investment. The company plans to expand partnerships and international growth.DealStreetAsiaAugust Global Partners leads $10m round for US medical device companyAugust Global Partners led a $10-million convertible note financing for Shape Memory Medical, a California-based medical device company. The funding will support its AAA-SHAPE pivotal trial and FLAGSHIP feasibility study for aortic disease treatments. The company's products have regulatory approvals in over 40 countries and have been used in more than 3,500 patients worldwide.FinSMEsORiS Raises €5M in Pre-Seed FundingORiS, a Turin-based laser-based wireless power transmission developer, raised €5M in pre-seed funding, including a €4.5M equity round led by Earlybird Venture Capital and a €0.5M regional grant. The funds will expand its engineering team, build clean-room facilities, and accelerate R&D on thermal and optical subsystems. The company plans to deliver its first flight module to partner DCUBED by late July 2026, ahead of a 2027 in-orbit demonstration.VestbeeAirbus Defence and Space becomes anchor LP in Earlybird and AVP's €500M E2D fundAirbus Defence and Space became anchor limited partners in E2D, a €500M dual-use and defence technology fund launched by Earlybird and AVP. The fund's first investment is in French startup Alta Ares, which develops AI-powered ISR and counter-UAS systems. Airbus and Alta Ares signed an MOU to integrate counter-drone solutions into Airbus' battle management suite.VestbeeORiS lands €5M to build laser-powered energy infrastructure for satellitesORiS, an Italian deeptech firm, secured €5 million in funding led by Earlybird to build laser-powered wireless power transmission for satellites and drones. The Turin-based startup also received a €500,000 grant from the Piedmont Region. The capital will accelerate development and expand its engineering team.deutsche-startups.de6 aufstrebende Startups, die mehr Menschen kennen solltenSix German startups—Causa Prima, bayshore, Fusion Bionic, INXM, Tawo, and Maple Aviation—raised between €4M and $10M in recent weeks. The funds will support engineering, product, and operational expansion. The startups span AI finance, legal tech, industrial lasers, process execution, construction, and drone logistics.VestbeeQuantumDiamonds secures €91M to revolutionize chip inspection with quantum sensingQuantumDiamonds raised €91 million, including €15 million in equity led by World Fund and €76 million in non-dilutive funding under the European Chips Act. The Munich-based firm develops quantum sensing tools for chip defect detection, with systems deployed by nine of the world's ten largest chip manufacturers. The capital will scale production and support a €152 million Munich facility.Tech.euChip testing startup QuantumDiamonds raises €15M in equity fundingQuantumDiamonds, a German chip-testing startup spun from TUM, raised €15M in equity led by World Fund. The round complements €76M in non-dilutive state funding, totaling €91M, to scale production of its quantum-sensing technology. The startup plans to more than double its engineering team over 12 months.Startuprad.io Startup PodcastStartup News Germany, Austria, Switzerland for June 2026DACH startups saw over 1.7 billion euros in defence-linked capital in June 2026, including STARK's 500 million euro Series C and KNDS's 15-18 billion euro IPO. Germany deployed 4.04 billion dollars across 188 rounds, down 20.7% year-over-year, with four new unicorns. Isar Aerospace raised 270 million euros but scrubbed its launch.Pulse 2.0Bayshore Raises $8 Million To Turn Legal And Compliance Rules Into Auditable AI AgentsBayshore, a Munich-based legal and compliance technology startup, announced it has raised $8 million in seed funding led by Earlybird Venture Capital, with participation from Lucid Capital, BOOOM, Heliad, and strategic angel investors. The company is emerging from stealth with a platform that transforms regulations, company policies, and rulesets into machine-readable code powering auditable AI agents for enterprise compliance workflows. Multiple Global 2000 organizations are already implementing the platform, and Bayshore plans to use the funding to continue platform development, expand its team, and support deployments in highly regulated industries.